Posts

Can Intellia's lonvo-z Turn CRISPR Promise into HAE Practice?

on

Intellia Therapeutics Advances In Vivo CRISPR Therapy Lonvo-z to FDA After Positive Phase 3 HAELO Trial Results

on

FDA Fully Lifts Clinical Hold on Intellia Therapeutics' CRISPR Gene Therapy Trials for ATTR Amyloidosis

on

FDA Lifts Clinical Hold on Intellia's MAGNITUDE-2 Phase 3 Trial for Nex-Z in ATTRv-PN

on

Patient Hospitalized After Receiving Intellia's CRISPR Therapy Dies, Prompting FDA Hold on Trials

on

Intellia Pauses Two CRISPR Trials After Severe Liver Toxicity Hospitalizes Patient

on

Analysts Downplay Intellia Adverse Event, but Gene Therapy Safety Remains Under Scrutiny

on

Analysts Downplay Intellia Adverse Event, but Gene Therapy Safety Remains Under Scrutiny

on